Precision Medicine Intervention in Severe Asthma (PRISM) Clinical Study

From WikiMD's Wellness Encyclopedia

The PRISM Clinical Study is an international, multi-center research effort with an ambitious objective: to drastically reduce the frequency and severity of asthma attacks in individuals suffering from severe asthma by employing precision medicine. The study uses the principles of precision medicine, which uses information about a person's genes, proteins, and environment to prevent, diagnose, and treat disease. In asthma, precision medicine aims to tailor treatments based on an individual's unique profile, thus improving efficacy and minimizing side effects.

The PRISM study commenced in 2022 and is projected to conclude in 2026. The study is being sponsored by a consortium of universities, research institutions, and pharmaceutical companies, and is subject to oversight by institutional review boards and ethics committees.

Study Design[edit | edit source]

The PRISM study utilizes a randomized, controlled, double-blind design to eliminate bias and provide a high level of evidence on the efficacy of precision interventions. The participants, all of whom have severe asthma, are divided into two groups. The control group receives standard care, while the experimental group receives personalized treatment plans developed based on their unique genetic and environmental profiles.

Data from a range of sources is used to develop these personalized plans, including:

  • Genomic sequencing to identify relevant genetic variants
  • Detailed environmental exposure histories
  • Comprehensive assessments of lung function and inflammation
  • Regular monitoring of symptoms and quality of life

Preliminary Results[edit | edit source]

While the study is ongoing, preliminary results released in 2023 indicated that the PRISM approach has the potential to significantly improve the lives of people with severe asthma. Participants in the experimental group experienced fewer and less severe asthma attacks compared to the control group. Furthermore, these participants reported higher quality of life scores and fewer side effects from medication.

Future Implications[edit | edit source]

The PRISM Clinical Study is expected to bring about a revolution in the management of severe asthma. The study will provide valuable evidence on the efficacy of precision medicine approaches in reducing asthma attacks and improving quality of life in patients with severe asthma. It will also help to identify new therapeutic targets and contribute to the development of novel treatments for severe asthma.

Furthermore, the PRISM study has broader implications for the field of precision medicine. Its innovative use of personalized medicine in a common, chronic disease like asthma provides a model for the application of precision medicine in other diseases.

See Also[edit | edit source]

References[edit | edit source]

Precision Medicine Intervention in Severe Asthma (PRISM) Clinical Study Resources
Wikipedia
WikiMD
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD

Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.com/w/index.php?title=Precision_Medicine_Intervention_in_Severe_Asthma_(PRISM)_Clinical_Study&oldid=4962192"

Contributors: Prab R. Tumpati, MD